The Acquired Immunodeficiency Syndrome: General Overview

References

• Barre‐Sinoussi F., Chermann J. C., Rex R. Isolation of a T‐lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868–871
   PubMed Web of Science ®Google Scholar
• Biggar R. J. The AIDS problem in Africa. Lancet 1986; 79–82
   PubMed Web of Science ®Google Scholar
• Brunet J. B., Ancelle R. A. The International occurrence of the Acquired Immunodeficiency Syndrome. Annals Internal Medicine 1985; 103: 670–674
   PubMed Web of Science ®Google Scholar
• CDC. Pneumocystis Pnemonia –‐ Los Angeles. Morbidity and Mortality Weekly Reports 1981; 30: 250–252
   PubMedGoogle Scholar
• CDC. Kaposi's Sarcoma and Pneumocystis pneumonia among homosexual men – New York City and California. Mordidity and Mortality Weekly Reports 1981; 30: 305–208
   PubMedGoogle Scholar
• CDC. Revision of the case definition of Acquired Immunodeficiency Syndrome for national reporting –‐ United States. Morbidity and Mortality Weekly Reports 1985; 34: 373–375
   PubMedGoogle Scholar
• CDC. Update. Acquired Immunodeficiency Syndrome – United States. Morbidity and Mortality Weekly Reports 1986; 35: 17–21
   PubMedGoogle Scholar
• CDC. Antibodies to a retrovirus etiologically associated with the Acquired Immunodeficiency Syndrome (AIDS) in populations with increased incidences of the syndrome. Morbodity and Mortality Weekly Report 1984; 33: 377–379
   PubMedGoogle Scholar
• CDC. Classification system for human T‐lymphotropic virus type III/lymphadenopathy‐associated virus infections. Morbidity and Mortality Weekly Report 1986; 35: 334–449
   PubMedGoogle Scholar
• CDC. Recommendations for assisting in the prevention of perinatal transmission of human T‐lymphotropic virus type III/lymphadenopathy associated virus and the Acquired Immunodeficiency Syndrome. Morbidity and Mortality Weekly Report 1985; 48: 721–732
   Google Scholar
• Cooper D. A., Gold J., Maclean P. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1985; 1: 537–540
   PubMed Web of Science ®Google Scholar
• Curran J., Lawrence D. H., Jaffe H. Acquired Immunodeficiency Syndrome (AIDS) associated with transfusions. New England Journal of Medicine 1984; 310: 69–75
   PubMed Web of Science ®Google Scholar
• Curran J. W., Morgan W. M., Hardy A. M., Jaffe H. W., Darrow W. W., Dowdle W. R. The epidemiology of AIDS: Current status and future prospects. Science 1985; 229: 1352–1357
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. New York State Division of substance Abuse Services, (personal communication)
   Google Scholar
• Feorino P. M., Jaffe H. W., Palmer E. Transfusion‐associated Acquired Immunodeficiency Syndrome: evidence for persistent infection in blood donors. New England Journal of Medicine 1985; 312: 1293–1296
   PubMed Web of Science ®Google Scholar
• Frances D. P., Petricciani J. C. Prospect and pathways toward a vaccine for AIDS. New England Journal of Medicine 1985; 313: 1586–1590
   PubMed Web of Science ®Google Scholar
• Friedland G. H., Harris C., Butkus‐Small C., Shine D., Moll B., Darrow W., Klein R. Intravenous drug abusers and the Acquired Immunodeficiency Syndrome. Archives of Internal Medicine 1985; 145: 1213–1417
   Google Scholar
• Friedland G. H., Saltzman B. R., Rogers M. F., Kahl P. A., Lesser M. L., Mayers M. M., Klein R. S. Lack of transmission of HTLV‐III/LAV infection to household contacts of patients with AIDS and AIDS‐related‐complex with oral candidiasis. New England Journal of Medicine 1986; 314: 344–349
   PubMed Web of Science ®Google Scholar
• Gallo R. C., Salhuddin S. Z., Papovic M. Frequent detection and isolation of cytopathic retroviruses from patients with AIDS and at risk for AIDS. Science 1984; 224: 500–503
   PubMed Web of Science ®Google Scholar
• Goedert J. J., Biggar R. S., Weiss S. H. Three ‐year incidence of AIDS in five cohorts of HTLV‐III infected risk group members. Science 1986; 231: 992–995
   PubMed Web of Science ®Google Scholar
• Harris C. A., Cabridilla C. D., Robert‐Guroff H., Klein R. S., Friedland G. H., Getchell J. P., Saltzman B. R., Kalyanaraman V. S., Catalano M. T., Hewlett J. M., Gallo R. C., Steigbigel N. H. HTLV‐III/LAV infection and AIDS in heterosexual partners of AIDS patients. Interscience conference on antimicrobial agents and chemotherapy, Minneapolis, MN
   Google Scholar
• Henderson D. K., Saah A. J., Zak B. J. Risk of nosocomial infection with human T‐cell lymphotropic virus type III/lymphadenopathy‐associated virus in a large cohort of intensively exposed health care workers. Annals Internal Medicine 1986; 104: 644–647
   PubMed Web of Science ®Google Scholar
• Ho D., Bynington R. E., Schooley R. T., Flynn T., Rota T., Hirsh M. Infrequency of isolation of HTLV‐III virus from saliva in AIDS. New England Journal of Medicine 1985; 313: 1606
   PubMed Web of Science ®Google Scholar
• Ho D., Rota T., Schooley R. T., Kaplan J. C., Allan J. D., Groopman J., Resnick L., Felsen‐stein D., Andrews C., Hirsch M. Isolation of HTLV‐III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the Acquired Immunodeficiency Syndrome. New England Journal of Medicine 1985; 313: 1493–1497
   PubMed Web of Science ®Google Scholar
• Jaffe H. W., Choi K., Thomas P. A. National case‐control study of Kaposis Sarcoma and Pneumocystis carinii pneumonia in homosexual men: 1. Epidemiologic results. Annals of Internal Medicine 1983; 99: 145–151
   PubMed Web of Science ®Google Scholar
• Jaffe H. W., Darrow W. W., Echenberg D. F. The Acquired Immunodeficiency Syndrome in a cohort of homosexual men – a six year followup. Annals of Internal Medicine 1985; 103: 210–214
   PubMed Web of Science ®Google Scholar
• Kriess J., Koech D., Plummer F. AIDS virus infection in Nairobi prostitutes. New England Journal of Medicine 1986; 314: 414–418
   PubMed Web of Science ®Google Scholar
• McCray E. The Cooperative Needlestick Surveillance Group, Occupational risk of the Acquired Immunodeficiency Syndrome among health care workers. New England Journal of Medicine 1986; 314: 1127–1132
   PubMed Web of Science ®Google Scholar
• Needlestick transmission of HTLV‐III from a patient infected in Africa. Lancet 1984; 2: 1376–1377
   PubMed Web of Science ®Google Scholar
• Robertson J. R., Bucknall A. B. V., Welsby P. D., Roberts J. J. K., Inglis J. M., Peutherer J. F., Brettle R. P. Epidemic of AIDS related virus (HTLV‐III/LAV) infection among intravenous drug abusers. British Medical Journal 1986; 292: 517–529
   Google Scholar
• Saltzman B. R., Vileno J., Kahl P., Hewlett J., Klein R. S., Friedland H. G., Harris C. A. Special features of AIDS in an urban heterosexual population. Interscience conference on antimicrobial agents and chemotherapy, Minneapolis, MN., October, 1985
   Google Scholar
• Stricof R. L., Morse D. L. HTLV‐III/LAV seroconversion following a deep intramuscular needlestick injury. New England Journal of Medicine 1986; 314: 1115
   PubMed Web of Science ®Google Scholar
• Vogh M. W., Craven D. E., Crawford D. F., Witt D. J., Bylington R., Schooley R. T., Hirsch M. Isolation of HTLV‐III/LAV from cervical secretions of women at risk for AIDS. The lancet 1986; 525–527
   Web of Science ®Google Scholar
• Weiss S. H., Goedert S. S., Sarngadharan M. G. Screening test for HTLV‐III/LAV (AIDS agent) antibodies: Specificity, sensitivity, and applications. Journal of American Medical Association 1985; 253: 221–225
   PubMed Web of Science ®Google Scholar